NEW YORK (Reuters) - The recent volatility in the global stock market may make some investors feel queasy, but it is providing a buying opportunity in biotechnology stocks.
from Reuters: Business News http://ift.tt/2BU91oR
Wednesday, February 28, 2018
Home »
business news
,
latest business news
» Why Oppenheimer Global fund is focusing on biotech as rates rise
Why Oppenheimer Global fund is focusing on biotech as rates rise
Train drivers accept pay deal to end strike action
Aslef said 96.6% of its members who voted backed the deal, marking the end of long-running strikes. from BBC News https://ift.tt/LxCn1G9
0 comments:
Post a Comment